Table 1.
Limits of detection (LOD), percent detection and distribution of creatinine corrected urine concentrations of phenols, phthalates, parabens, and triclocarban in 751 SELF participants (2010–2012) included in this analysis and NHANES urine samples for non-Hispanic Black and non-Hispanic white Americans from the 2011–2012 survey year.(U.S. CDC, 2018)
| SELF participants, (N=751) | NHANES non-Hispanic Black American | NHANES non-Hispanic white Americans | |||||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| LOD (ng/mL) | % Detected | Median (Range), μg/g creatinine | Mean (SD), μg/g creatinine | 90th percentile, μg/g creatinine | 2011–2012 Geometric Mean, μg/g creatinine | 2011–2012 Geometric Mean, μg/g creatinine | |
|
| |||||||
| Phenols | |||||||
| BP3 | 0.4 | 99.3 | 13.3 (0.1, 18698.9) | 151.9 (1121.4) | 203.5 | 11.3 | 31.2 |
| BPA | 0.2 | 99.9 | 1.7 (0.2, 527.5) | 3.3 (19.6) | 4.5 | 1.7 | 1.8 |
| BPF1 | 0.2 | 79.6 | 0.3 (0.1, 213.2) | 3.5 (14.7) | 6.6 | 0.4 | 0.6 |
| BPS1 | 0.1 | 97.3 | 0.3 (0.1, 56.3) | 0.9 (3.5) | 1.5 | 0.5 | 0.4 |
| 2,4-dichlorophenol | 0.1 | 98.3 | 0.5 (0.1, 415.9) | 1.7 (15.5) | 1.7 | 1.0 | 0.7 |
| 2,5-dichlorophenol | 0.1 | 99.6 | 2.4 (0.1, 18354.4) | 48.5 (684.9) | 27.0 | 12.9 | 3.4 |
| Triclosan | 1.7 | 91.3 | 7.2 (0.4, 1721.6) | 37.1 (116.1) | 77.5 | 10.5 | 11.7 |
| Triclocarban 1 | 0.1 | 78.8 | 0.2 (0.1, 291.1) | 6.9 (23.9) | 14.5 | 0.4 | NC3 |
| Phthalates | |||||||
| MBP | 0.4 | 99.9 | 16.0 (1.2, 3262.4) | 26.8 (123.0) | 38.6 | 10.3 | 7.9 |
| MBzP | 0.3 | 99.7 | 6.5 (0.6, 445.3) | 11.5 (24.6) | 20.4 | 5.8 | 5.0 |
| MCNP | 0.2 | 99.7 | 2.8 (0.2, 171.0) | 4.7 (8.5) | 8.6 | 2.4 | 3.1 |
| MCOP | 0.3 | 100 | 19.9 (1.6, 1126.4) | 50.5 (89.8) | 116.7 | 18.7 | 24.3 |
| MCPP | 0.4 | 98.0 | 2.2 (0.2, 3128.9) | 14.5 (122.2) | 17.3 | 2.8 | 3.7 |
| MECPP | 0.4 | 99.9 | 15.1 (1.3, 376.8) | 21.6 (25.5) | 41.2 | 12.8 | 14.3 |
| MEHHP | 0.4 | 99.7 | 11.8 (0.6, 319.2) | 17.3 (22.0) | 31.2 | 8.8 | 8.7 |
| MEHP | 0.8 | 91.5 | 2.3 (0.2, 76.8) | 3.7 (5.3) | 7.4 | 1.5 | 1.5 |
| MEOHP | 0.2 | 99.7 | 7.4 (0.5, 168.3) | 10.6 (12.7) | 20.1 | 5.7 | 5.6 |
| MEP | 1.2 | 100 | 59.5 (4.8, 6694.4) | 133.9 (353.7) | 251.6 | 69.4 | 37.0 |
| MHBP2 | 0.4 | 93.7 | 1.2 (0.1, 359.6) | 2.1 (13.4) | 2.8 | 0.8 | 0.9 |
| MHiBP1 | 0.4 | 99.2 | 3.0 (0.4, 227.6) | 4.5 (9.3) | 7.7 | 2.7 | 2.4 |
| MiBP | 0.8 | 99.3 | 11.2 (0.5, 652.6) | 16.7 (30.4) | 26.6 | 7.7 | 6.4 |
| MNP | 0.9 | 72.0 | 1.1 (0.1, 196.3) | 4.2 (11.5) | 9.3 | 1.1 | NC3 |
| MHiNCH | 0.4 | 24.0 | NC3 | NC3 | NC3 | NC3 | NC3 |
| MCOCH2 | 0.5 | 11.5 | NC3 | NC3 | NC3 | 0.7 | NC3 |
| Parabens | |||||||
| Ethyl Paraben | 1.0 | 78.7 | 2.4 (0.2, 1280.0) | 20.3 (84.4) | 35.3 | NC3 | NC3 |
| Methyl Paraben | 1.0 | 100 | 116.1 (1.6, 11364.6) | 282.3 (593.6) | 717.8 | 123.0 | 31.0 |
| Propyl Paraben | 0.1 | 100 | 16.4 (0.1, 1285.4) | 52.5 (111.8) | 124.3 | 12.8 | 5.1 |
| Butyl Paraben | 0.1 | 57.5 | NC3 | NC3 | NC3 | NC3 | NC3 |
1
NHANES data from the 2013 – 2014 cycle.
2
NHANES data from the 2015 – 2016 cycle.
3
Not calculated due to a high percentage of samples with concentrations <LOD.